Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Jul 13, 2022
As per the WHO, roughly 50 million people worldwide have Epilepsy. The burden of Epilepsy is growing in almost every geographic region. According to the Global Burden of Disease report on the burden of neurological diseases, it is observed that idiopathic epilepsy accounted for 5% of all neurological DALYs and 1.3%...
Read More...
Jun 15, 2021
Eclipse Launches MicroPen EVO™ Advanced Micro-needling Device On June 01, 2021, Eclipse, a leading aesthetic and medical manufacturer, received FDA clearance of their latest medical-grade micro-needling device, the MicroPen EVO. It had launched MicroPen EVO in Canada last year and now will make it availab...
Read More...
Nov 16, 2020
Potential and growth of the current market The major drawback of the current antiepileptic drugs (AEDs) is their modest efficacy even at best; therefore, many patients require as many as four concurrent AEDs and contend with their host of side effects. The epilepsy market has witnessed several approvals in the l...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper